Related Experiment Video
Updated: Jun 8, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
Methylxanthines and the kidney
Hartmut Osswald1, Jürgen Schnermann
1Department of Pharmacology and Toxicology, University of Tübingen, Wilhelmstrasse 56, 72074, Tübingen, Germany.
Caffeine and theophylline, natural methylxanthines, mildly increase urine output by inhibiting kidney tubule reabsorption via adenosine A1 receptor antagonism. While effective in animal models for preventing kidney injury, human data is insufficient to confirm therapeutic efficacy.
Area of Science:
- Nephrology
- Pharmacology
- Renal Physiology
Background:
- Theophylline was historically used as a diuretic before modern diuretics emerged.
- Methylxanthines like caffeine and theophylline influence kidney function through various mechanisms.
Purpose of the Study:
- To elucidate the effects of natural methylxanthines (caffeine and theophylline) on kidney function.
- To investigate the role of adenosine A1 receptors in methylxanthine-induced diuresis and renal protection.
Main Methods:
- Utilized adenosine receptor antagonists and gene-deleted mice (A1AR knockout) to study methylxanthine action.
- Examined the vasodilatory effects and renin secretion stimulation by methylxanthines.
- Reviewed experimental animal data on theophylline's efficacy in various renal impairment models.
Main Results:
- Methylxanthines inhibit proximal tubule fluid reabsorption, primarily through adenosine A1 receptor antagonism.
- Caffeine and theophylline act as weak renal vasodilators and stimulate renin secretion.
- Experimental animals showed functional improvements in nephrotoxic and ischemic renal injury models with theophylline treatment.
Conclusions:
- Methylxanthines' diuretic effect is mainly mediated by adenosine A1 receptor antagonism in the proximal tubule.
- Theophylline demonstrates potential therapeutic benefits in experimental models of renal injury.
- Clinical evidence is lacking to confirm the efficacy of methylxanthines in preventing human nephrotoxic or post-ischemic renal injury.
Related Concept Videos
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinergic Antagonists: Pharmacokinetics
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Direct-Acting Cholinergic Agonists: Pharmacokinetics
